adenosine diphosphate has been researched along with Carcinosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrov, LB; Altwerger, G; Andikyan, V; Azodi, M; Bellone, S; Choi, J; Clark, M; Harold, J; Hartwich, TMP; Huang, GS; Jeong, K; Manara, P; Manavella, DD; Menderes, G; Mutlu, L; Ratner, E; Santin, AD; Schwartz, PE; Tymon-Rosario, JR; Yang, K; Yang-Hartwich, Y; Zipponi, M | 1 |
| Bradley, CJ; Connellan, JM; Dauer, RJ; Thurlow, PJ | 1 |
2 other study(ies) available for adenosine diphosphate and Carcinosarcoma
| Article | Year |
|---|---|
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.
Topics: Adenosine Diphosphate; Animals; Carcinosarcoma; Cell Line, Tumor; Female; Homologous Recombination; Humans; Ovarian Neoplasms; Ovary; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ribose | 2022 |
Characterization of platelet aggregation induced by the human carcinosarcoma Colo 526: role of platelet activation, tumor cell cytoskeleton and tumor cell plasma membrane.
Topics: Adenosine Diphosphate; Carcinosarcoma; Cell Division; Cell Membrane; Culture Media, Serum-Free; Cytoskeleton; Female; Humans; Microscopy, Electron; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors; Tumor Cells, Cultured; Uterine Neoplasms | 1997 |